![Ambion™ Silencer™ Select Pre-Designed siRNA: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific Ambion™ Silencer™ Select Pre-Designed siRNA: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/product-images/F572293~p.eps-650.jpg)
Ambion™ Silencer™ Select Pre-Designed siRNA: RNAi and RNA Reagents Molecular Biology Reagents and Kits | Fisher Scientific
![Methods and compositions for selecting siRNA of improved functionality Patent Grant Khvorova , et al. June 30, 2 [Thermo Fisher Scientific Inc.] Methods and compositions for selecting siRNA of improved functionality Patent Grant Khvorova , et al. June 30, 2 [Thermo Fisher Scientific Inc.]](https://uspto.report/patent/grant/10696968/US10696968-20200630-D00000.png)
Methods and compositions for selecting siRNA of improved functionality Patent Grant Khvorova , et al. June 30, 2 [Thermo Fisher Scientific Inc.]
![High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins | Scientific Data High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-021-00924-9/MediaObjects/41597_2021_924_Fig1_HTML.png)
High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins | Scientific Data
![A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/ca908dae-790a-4b91-a3b8-087756edbf99/gr1.jpg)
A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi: Molecular Therapy - Nucleic Acids
![Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00575/article_deploy/html/images/pharmaceuticals-15-00575-g001.png?1652233685)
Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
![Thermo-Responsive Polymer-siRNA Conjugates Enabling Artificial Control of Gene Silencing around Body Temperature | SpringerLink Thermo-Responsive Polymer-siRNA Conjugates Enabling Artificial Control of Gene Silencing around Body Temperature | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11095-022-03414-8/MediaObjects/11095_2022_3414_Fig1_HTML.png)
Thermo-Responsive Polymer-siRNA Conjugates Enabling Artificial Control of Gene Silencing around Body Temperature | SpringerLink
![ThermoFisher/Life Technologies » Genetic Resources Core Facility, Johns Hopkins University, School of Medicine ThermoFisher/Life Technologies » Genetic Resources Core Facility, Johns Hopkins University, School of Medicine](http://grcf.jhmi.edu/wp-content/uploads/2022/07/Thermo-Fisher-Scientific_logo_cmyk_ez.webp)
ThermoFisher/Life Technologies » Genetic Resources Core Facility, Johns Hopkins University, School of Medicine
![Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/0dca4bd6-cb0a-454b-82ee-3b5168b6fde7/fx1.jpg)
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids
![A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant | EMBO Molecular Medicine A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/be8e63aa-1b3f-4d5e-98f4-b7536ca12661/emmm202115298-abs-0001-m.jpg)